- Home
- SEER vs RPID Comparison
SEER vs RPID Comparison
Compare SEER & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- RPID
- Stock Information
- Founded
- SEER 2017
- RPID 2006
- Country
- SEER United States
- RPID United States
- Employees
- SEER N/A
- RPID N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- RPID Medical Specialities
- Sector
- SEER Health Care
- RPID Health Care
- Exchange
- SEER Nasdaq
- RPID Nasdaq
- Market Cap
- SEER 125.3M
- RPID 138.9M
- IPO Year
- SEER 2020
- RPID 2021
- Fundamental
- Price
- SEER $2.29
- RPID $3.63
- Analyst Decision
- SEER Hold
- RPID Buy
- Analyst Count
- SEER 1
- RPID 1
- Target Price
- SEER $3.00
- RPID $8.00
- AVG Volume (30 Days)
- SEER 172.5K
- RPID 81.8K
- Earning Date
- SEER 08-07-2025
- RPID 08-01-2025
- Dividend Yield
- SEER N/A
- RPID N/A
- EPS Growth
- SEER N/A
- RPID N/A
- EPS
- SEER N/A
- RPID N/A
- Revenue
- SEER $15,309,000.00
- RPID $29,645,000.00
- Revenue This Year
- SEER $26.18
- RPID $18.54
- Revenue Next Year
- SEER $29.58
- RPID $20.55
- P/E Ratio
- SEER N/A
- RPID N/A
- Revenue Growth
- SEER N/A
- RPID 28.36
- 52 Week Low
- SEER $1.56
- RPID $0.58
- 52 Week High
- SEER $2.63
- RPID $4.04
- Technical
- Relative Strength Index (RSI)
- SEER 65.36
- RPID 58.15
- Support Level
- SEER $1.94
- RPID $3.33
- Resistance Level
- SEER $2.03
- RPID $3.77
- Average True Range (ATR)
- SEER 0.07
- RPID 0.24
- MACD
- SEER 0.02
- RPID -0.01
- Stochastic Oscillator
- SEER 98.51
- RPID 81.82
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.